David Josephson, MD
Urology · Los Angeles, CANPI 1063510840
Payments from drug & device makers
Across 423 payments — averaging $3428.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Blue Earth Diagnostics$697K
- Progenics Pharmaceuticals, Inc.$623K
- Sumitomo Pharma America, Inc.$39K
- Intuitive Surgical$23K
- Astrazeneca UK Limited$20K
- Bayer$14K
- plus $34K from 41 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,450,177 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Los Angeles
- Karim ChamieLos Angeles$4.3M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.7M
- Brian ShuchLos Angeles$1.5M
- Saum GhodoussipourLos Angeles$1.1M
- Stuart HoldenLos Angeles$1.1M
- William AronsonLos Angeles$951K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.